查看中文
yiying.wang@cooley.com
Yiying Wang represents companies, investment banks and private equity funds in IPOs in the US and Hong Kong capital markets, cross-border M&A transactions, and various other corporate transactions.
Download full bio
Keymed Biosciences – HK$3.1 Billion IPO
Capital Markets
Mergers & Acquisitions
Private Equity
Life Sciences
Asia
Columbia Law SchoolLLM
Peking University Law SchoolLLB
New York
Keymed Biosciences – HK$3.1 Billion IPO July 8, 2021
+86 21 6030 0660
Locations